Continuous therapy in HHV-8 negative Multicentric Castleman Disease and prolonged progression-free survival

Abstract The optimal treatment endpoints and duration of continuous therapy for multicentric Castleman disease (MCD) remain controversial. We retrospectively analyzed data from 123 patients with Human Herpesvirus (HHV)-8 negative MCD. We demonstrated that continuous therapy significantly enhanced pr...

Full description

Bibliographic Details

Published in:	Journal of Hematology & Oncology
Main Authors:	Yi Liu, Xuejiao Yin, Shengnan Ding, Jiaying Ge, Liya Ma, Min Yang, Xuxia Luo, Chengli Zhong, Sishi Fang, Qiumei Yao, Li Zhu, Wenjuan Yu, Liping Mao, Juying Wei, Xingnong Ye, De Zhou, Hongyan Tong, Haitao Meng, Jie Jin, Liangshun You
Format:	Article
Language:	English
Published:	BMC 2024-08-01
Subjects:	Castleman Disease HHV-8 negative Multicentric Castleman Disease Continuous therapy
Online Access:	https://doi.org/10.1186/s13045-024-01588-9